Peter M. Elias
Chief Tech/Sci/R&D Officer at Ceragenix Corp.
Profile
Peter M.
Elias is currently the Chief Scientific Officer at Ceragenix Corp.
He previously held the same position at OnSource Corp.
and Ceragenix Pharmaceuticals, Inc. Elias received his undergraduate degree from Stanford University and his graduate and doctorate degrees from The University of California, San Francisco.
Peter M. Elias active positions
| Companies | Position | Start |
|---|---|---|
| Ceragenix Corp. | Chief Tech/Sci/R&D Officer | 30/04/2004 |
Former positions of Peter M. Elias
| Companies | Position | End |
|---|---|---|
| OnSource Corp. | Chief Tech/Sci/R&D Officer | 26/06/2005 |
Ceragenix Pharmaceuticals, Inc.
 Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | Chief Tech/Sci/R&D Officer | - |
Training of Peter M. Elias
| Stanford University | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
| OnSource Corp. | Consumer Services |
Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | Health Technology |
| Ceragenix Corp. |
- Stock Market
- Insiders
- Peter M. Elias
